Design, Properties, and Effective Use of the Oral Chelator L1 and Other
- 17 December 1990
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 612 (1), 339-350
- https://doi.org/10.1111/j.1749-6632.1990.tb24321.x
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- EFFICACY AND SAFETY OF ORAL IRON CHELATOR L1 IN ANAEMIC RHEUMATOID ARTHRITIS PATIENTSThe Lancet, 1989
- CLINICAL TRIALS WITH ORAL IRON CHELATOR L1The Lancet, 1989
- SAFETY OF ORAL IRON CHELATOR L1The Lancet, 1989
- AGRANULOCYTOSIS AND THROMBOCYTOPENIA IN PATIENT WITH BLACKFAN-DIAMOND ANAEMIA DURING ORAL CHELATOR TRIALThe Lancet, 1989
- Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.BMJ, 1987
- NEW ORALLY ACTIVE IRON CHELATORSThe Lancet, 1985
- Absorption, excretion and tissue distribution of 2-pyridinethiol-1-oxideFood and Cosmetics Toxicology, 1977
- Potential wool growth inhibitors. Improved syntheses of mimosine and related 4(1H)-PyridonesAustralian Journal of Chemistry, 1976
- Metabolism of ethyl maltol and maltol in the dogJournal of Agricultural and Food Chemistry, 1971
- Analogs of Aspergillic Acid. II. Various Antibacterial Heterocyclic Hydroxamic AcidsJournal of the American Chemical Society, 1949